The News
An Interview with Shahin Gharakhanian PDF Print E-mail
Written by Alain Lafeuillade   
Thursday, 23 April 2015 11:19

An Interview with Shahin Gharakhanian

SG

Doctor Gharakhanian practiced clinical HIV medicine for almost 20 years at AP-HP academic Hospitals in Paris, having trained there in Infectious Diseases / HIV Medicine and been mentored by Willy Rozenbaum, co-discoverer of the HIV virus (Science, 1983). As a clinical practitioner, his principal academic focus was on PCP, Kaposi’s sarcoma and HIV-associated lipodystrophy/metabolic syndrome. He then moved on to R&D in the pharmaceutical industry, were he has worked on opportunistic infections and anti-retrovirals … In Vertex Pharmaceuticals, Inc, he co-led the clinical development & FDA NDA/EMA approval of fosamprenavir for them in collaboration with GSK, and also developed telaprevir in HIV/HCV co-infection. Since 2011, he has been more closely involved in HIV therapeutic vaccines and HIV functional cure research. During the past four years, he has, therefore, been working on two different vaccines and designed/worked with a team to set up a major international phase II clinical trial [NCT 02041247].

Last Updated on Thursday, 23 April 2015 15:12
Read more...
 
2015 HIV Persistence Workshop Update PDF Print E-mail
Written by Alain Lafeuillade   
Sunday, 08 March 2015 10:12

2015 HIV Persistence Workshop Update

1PW15LOGOFollowing a Recent Meeting of the Steering and Scientific Committees for this Year HIV Persistence Workshop to be held in Miami (Fl, USA), a series of changes have been decided.

Last Updated on Sunday, 08 March 2015 10:44
Read more...
 
Submit your Paper to HCT PDF Print E-mail
Written by Alain Lafeuillade   
Thursday, 26 February 2015 01:22

Submit your Papers to HIV Clinical Trials: new publishing company

HCTFormerly published by Thomas Land, the HIV Clinical Trials Journal is now published by Maney Publishing.

The new policy of the journal is to offer you rapid review and publishing process.

The journal is indexed in PubMed.

Read more...
 
TLR7 Agonist Induces Transient Viremia PDF Print E-mail
Written by Alain Lafeuillade   
Thursday, 26 February 2015 00:35

Data from 2015 CROI: Treatment with a TLR7 Agonist Induces Transient Viremia in SIV-infected-ART-Suppressed Monkey

croi2015_w280x100Interesting data presented this morning at the 2015 CROI in Seattle regarding a new compound developed by Gilead to target the reservoir.

Last Updated on Thursday, 26 February 2015 00:48
Read more...
 
An Interview with Robert Gallo PDF Print E-mail
Written by Alain Lafeuillade   
Tuesday, 03 February 2015 08:14

An Interview with Robert Gallo

1-gallo_7

Robert C. Gallo, MD, Director of the Institute of Human Virology (IHV) at the University of Maryland School of Medicine and International Scientific Director of the Global Virus Network (GVN). Since 1996, Dr. Robert C. Gallo has been Director of the Institute of Human Virology (IHV) and Professor of Medicine at the University of Maryland School of Medicine. He is also the Homer & Martha Gudelsky Distinguished Professor in Medicine and Co-Founder and International Scientific Director of the Global Virus Network (GVN). Previously (for 30 years) he was at the National Cancer Institute (NCI) in Bethesda, MD. While at NCI, he and his co-workers discovered interleukin-2 (Il-2) in 1976.

Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 5 of 39